Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1032

D-β-hydroxybutyrate

Intended Use: Intended for use as an ingredient at levels up to 6 g per serving in sports and nutritional beverages, bars, and gels.
Basis: Scientific procedures
Notifier: Osaka Gas Chemicals Co. Ltd.
Notifier Address: 2-37, Chiyozaki 3-cyome-minami
Nishi-ku, Osaka, 550-0023
Japan
GRAS Notice (releasable information): GRN 1032 with amendments (in PDF) (7.3 MB)
Date of closure: Jun 2, 2022
FDA's Letter: FDA has no questions (in PDF) (214 kB)
-
-